Recent research focusing on Tirzepatide at a dosage of 20mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may boost the drug's ability to regulate blood sugar, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully evaluate the